Favorable outcomes of localized synovial sarcoma patients with a high utilization rate of neoadjuvant and/or adjuvant chemotherapy

Synovial sarcoma (SS) is considered to be a chemosensitive, soft tissue sarcoma. Therefore, neoadjuvant and/or adjuvant chemotherapy (N/AC) is used for the treatment of high-risk SS patients. However, the role of N/AC remains controversial. The present study aimed to review the clinical outcomes of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: Outani, Hidetatsu, Kakunaga, Shigeki, Hamada, Kenichiro, Takenaka, Satoshi, Imura, Yoshinori, Nagata, Shigenori, Tanaka, Takaaki, Tamiya, Hironari, Oshima, Kazuya, Naka, Norifumi, Kudawara, Ikuo, Araki, Nobuhito, Ueda, Takafumi, Yoshikawa, Hideki
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587004/
https://ncbi.nlm.nih.gov/pubmed/31281649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1863
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars